Report Cover

Global mRNA Vaccines & Therapeutics Market Growth 2020-2025


According to this study, over the next five years the mRNA Vaccines & Therapeutics market will register a 34.7%% CAGR in terms of revenue, the global market size will reach $ 6166.3 million by 2025, from $ 1874.2 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in mRNA Vaccines & Therapeutics business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Vaccines & Therapeutics market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the mRNA Vaccines & Therapeutics, covering the supply chain analysis, impact assessment to the mRNA Vaccines & Therapeutics market size growth rate in several scenarios, and the measures to be undertaken by mRNA Vaccines & Therapeutics companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
    Infectious Disease Vaccines
    Cancer Vaccines

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
    Infectious Disease
    Cancer

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
    Moderna Therapeutics
    Tiba Biotechnology
    CureVac
    BioNTech
    Sangamo Therapeutics
    Translate Bio
    eTheRNA
    Argos Therapeutics
    Ethris
    In-Cell-Art

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
    To study and analyze the global mRNA Vaccines & Therapeutics consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
    To understand the structure of mRNA Vaccines & Therapeutics market by identifying its various subsegments.
    Focuses on the key global mRNA Vaccines & Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the mRNA Vaccines & Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of mRNA Vaccines & Therapeutics submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
    1.1 Market Introduction
    1.2 Research Objectives
    1.3 Years Considered
    1.4 Market Research Methodology
    1.5 Data Source
    1.6 Economic Indicators
    1.7 Currency Considered

2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global mRNA Vaccines & Therapeutics Consumption 2015-2025
        2.1.2 mRNA Vaccines & Therapeutics Consumption CAGR by Region
    2.2 mRNA Vaccines & Therapeutics Segment by Type
        2.2.1 Infectious Disease Vaccines
        2.2.2 Cancer Vaccines
    2.3 mRNA Vaccines & Therapeutics Consumption by Type
        2.3.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020)
        2.3.2 Global mRNA Vaccines & Therapeutics Revenue and Market Share by Type (2015-2020)
        2.3.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2015-2020)
    2.4 mRNA Vaccines & Therapeutics Segment by Application
        2.4.1 Infectious Disease
        2.4.2 Cancer
    2.5 mRNA Vaccines & Therapeutics Consumption by Application
        2.5.1 Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020)
        2.5.2 Global mRNA Vaccines & Therapeutics Value and Market Share by Type (2015-2020)
        2.5.3 Global mRNA Vaccines & Therapeutics Sale Price by Type (2015-2020)

3 Global mRNA Vaccines & Therapeutics by Company
    3.1 Global mRNA Vaccines & Therapeutics Sales Market Share by Company
        3.1.1 Global mRNA Vaccines & Therapeutics Sales by Company (2018-2020)
        3.1.2 Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2018-2020)
    3.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company
        3.2.1 Global mRNA Vaccines & Therapeutics Revenue by Company (2018-2020)
        3.2.2 Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2018-2020)
    3.3 Global mRNA Vaccines & Therapeutics Sale Price by Company
    3.4 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution, Sales Area, Type by Company
        3.4.1 Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area by Company
        3.4.2 Players mRNA Vaccines & Therapeutics Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion

4 mRNA Vaccines & Therapeutics by Regions
    4.1 mRNA Vaccines & Therapeutics by Regions
    4.2 Americas mRNA Vaccines & Therapeutics Consumption Growth
    4.3 APAC mRNA Vaccines & Therapeutics Consumption Growth
    4.4 Europe mRNA Vaccines & Therapeutics Consumption Growth
    4.5 Middle East & Africa mRNA Vaccines & Therapeutics Consumption Growth

5 Americas
    5.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries
        5.1.1 Americas mRNA Vaccines & Therapeutics Consumption by Countries (2015-2020)
        5.1.2 Americas mRNA Vaccines & Therapeutics Value by Countries (2015-2020)
    5.2 Americas mRNA Vaccines & Therapeutics Consumption by Type
    5.3 Americas mRNA Vaccines & Therapeutics Consumption by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
    5.8 Key Economic Indicators of Few Americas Countries

6 APAC
    6.1 APAC mRNA Vaccines & Therapeutics Consumption by Regions
        6.1.1 APAC mRNA Vaccines & Therapeutics Consumption by Regions (2015-2020)
        6.1.2 APAC mRNA Vaccines & Therapeutics Value by Regions (2015-2020)
    6.2 APAC mRNA Vaccines & Therapeutics Consumption by Type
    6.3 APAC mRNA Vaccines & Therapeutics Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
    7.1 Europe mRNA Vaccines & Therapeutics by Countries
        7.1.1 Europe mRNA Vaccines & Therapeutics Consumption by Countries (2015-2020)
        7.1.2 Europe mRNA Vaccines & Therapeutics Value by Countries (2015-2020)
    7.2 Europe mRNA Vaccines & Therapeutics Consumption by Type
    7.3 Europe mRNA Vaccines & Therapeutics Consumption by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
    7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
    8.1 Middle East & Africa mRNA Vaccines & Therapeutics by Countries
        8.1.1 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Countries (2015-2020)
        8.1.2 Middle East & Africa mRNA Vaccines & Therapeutics Value by Countries (2015-2020)
    8.2 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Type
    8.3 Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries

9 Market Drivers, Challenges and Trends
    9.1 Market Drivers and Impact
        9.1.1 Growing Demand from Key Regions
        9.1.2 Growing Demand from Key Applications and Potential Industries
    9.2 Market Challenges and Impact
    9.3 Market Trends

10 Marketing, Distributors and Customer
    10.1 Sales Channel
        10.1.1 Direct Channels
        10.1.2 Indirect Channels
    10.2 mRNA Vaccines & Therapeutics Distributors
    10.3 mRNA Vaccines & Therapeutics Customer

11 Global mRNA Vaccines & Therapeutics Market Forecast
    11.1 Global mRNA Vaccines & Therapeutics Consumption Forecast (2021-2025)
    11.2 Global mRNA Vaccines & Therapeutics Forecast by Regions
        11.2.1 Global mRNA Vaccines & Therapeutics Forecast by Regions (2021-2025)
        11.2.2 Global mRNA Vaccines & Therapeutics Value Forecast by Regions (2021-2025)
        11.2.3 Americas Consumption Forecast
        11.2.4 APAC Consumption Forecast
        11.2.5 Europe Consumption Forecast
        11.2.6 Middle East & Africa Consumption Forecast
    11.3 Americas Forecast by Countries
        11.3.1 United States Market Forecast
        11.3.2 Canada Market Forecast
        11.3.3 Mexico Market Forecast
        11.3.4 Brazil Market Forecast
   11.4 APAC Forecast byRegions
        11.4.1 China Market Forecast
        11.4.2 Japan Market Forecast
        11.4.3 Korea Market Forecast
        11.4.4 Southeast Asia Market Forecast
        11.4.5 India Market Forecast
        11.4.6 Australia Market Forecast
    11.5 Europe Forecast by Countries
        11.5.1 Germany Market Forecast
        11.5.2 France Market Forecast
        11.5.3 UK Market Forecast
        11.5.4 Italy Market Forecast
        11.5.5 Russia Market Forecast
    11.6 Middle East & Africa Forecast by Countries
        11.6.1 Egypt Market Forecast
        11.6.2 South Africa Market Forecast
        11.6.3 Israel Market Forecast
        11.6.4 Turkey Market Forecast
        11.6.5 GCC Countries Market Forecast
    11.7 Global mRNA Vaccines & Therapeutics Forecast by Type
    11.8 Global mRNA Vaccines & Therapeutics Forecast by Application

12 Key Players Analysis
    12.1 Moderna Therapeutics
        12.1.1 Company Information
        12.1.2 mRNA Vaccines & Therapeutics Product Offered
        12.1.3 Moderna Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.1.4 Main Business Overview
        12.1.5 Moderna Therapeutics Latest Developments
    12.2 Tiba Biotechnology
        12.2.1 Company Information
        12.2.2 mRNA Vaccines & Therapeutics Product Offered
        12.2.3 Tiba Biotechnology mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.2.4 Main Business Overview
        12.2.5 Tiba Biotechnology Latest Developments
    12.3 CureVac
        12.3.1 Company Information
        12.3.2 mRNA Vaccines & Therapeutics Product Offered
        12.3.3 CureVac mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.3.4 Main Business Overview
        12.3.5 CureVac Latest Developments
    12.4 BioNTech
        12.4.1 Company Information
        12.4.2 mRNA Vaccines & Therapeutics Product Offered
        12.4.3 BioNTech mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.4.4 Main Business Overview
        12.4.5 BioNTech Latest Developments
    12.5 Sangamo Therapeutics
        12.5.1 Company Information
        12.5.2 mRNA Vaccines & Therapeutics Product Offered
        12.5.3 Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.5.4 Main Business Overview
        12.5.5 Sangamo Therapeutics Latest Developments
    12.6 Translate Bio
        12.6.1 Company Information
        12.6.2 mRNA Vaccines & Therapeutics Product Offered
        12.6.3 Translate Bio mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.6.4 Main Business Overview
        12.6.5 Translate Bio Latest Developments
    12.7 eTheRNA
        12.7.1 Company Information
        12.7.2 mRNA Vaccines & Therapeutics Product Offered
        12.7.3 eTheRNA mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.7.4 Main Business Overview
        12.7.5 eTheRNA Latest Developments
    12.8 Argos Therapeutics
        12.8.1 Company Information
        12.8.2 mRNA Vaccines & Therapeutics Product Offered
        12.8.3 Argos Therapeutics mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.8.4 Main Business Overview
        12.8.5 Argos Therapeutics Latest Developments
    12.9 Ethris
        12.9.1 Company Information
        12.9.2 mRNA Vaccines & Therapeutics Product Offered
        12.9.3 Ethris mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.9.4 Main Business Overview
        12.9.5 Ethris Latest Developments
    12.10 In-Cell-Art
        12.10.1 Company Information
        12.10.2 mRNA Vaccines & Therapeutics Product Offered
        12.10.3 In-Cell-Art mRNA Vaccines & Therapeutics Sales, Revenue, Price and Gross Margin (2018-2020)
        12.10.4 Main Business Overview
        12.10.5 In-Cell-Art Latest Developments

13 Research Findings and Conclusion

List of Tables Table 1. Research Methodology Table 2. Data Source Table 3. mRNA Vaccines & Therapeutics Consumption CAGR by Region 2015-2025 ($ Millions) Table 4. Major Players of Infectious Disease Vaccines Table 5. Major Players of Cancer Vaccines Table 6. Global Consumption Sales by Type (2015-2020) Table 7. Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020) Table 8. Global mRNA Vaccines & Therapeutics Revenue by Type (2015-2020) ($ million) Table 9. Global mRNA Vaccines & Therapeutics Value Market Share by Type (2015-2020) ($ Millions) Table 10. Global mRNA Vaccines & Therapeutics Sale Price by Type (2015-2020) Table 11. Global Consumption Sales by Application (2015-2020) Table 12. Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2015-2020) Table 13. Global mRNA Vaccines & Therapeutics Value by Application (2015-2020) Table 14. Global mRNA Vaccines & Therapeutics Value Market Share by Application (2015-2020) Table 15. Global mRNA Vaccines & Therapeutics Sale Price by Application (2015-2020) Table 16. Global mRNA Vaccines & Therapeutics Sales by Company (2017-2019) (M Doses) Table 17. Global mRNA Vaccines & Therapeutics Sales Market Share by Company (2017-2019) Table 18. Global mRNA Vaccines & Therapeutics Revenue by Company (2017-2019) ($ Millions) Table 19. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company (2017-2019) Table 20. Global mRNA Vaccines & Therapeutics Sale Price by Company (2017-2019) Table 21. Global mRNA Vaccines & Therapeutics Manufacturing Base Distribution and Sales Area by Manufacturers Table 22. Players mRNA Vaccines & Therapeutics Products Offered Table 23. mRNA Vaccines & Therapeutics Concentration Ratio (CR3, CR5 and CR10) (2017-2019) Table 24. Global mRNA Vaccines & Therapeutics Consumption by Regions 2015-2020 (M Doses) Table 25. Global mRNA Vaccines & Therapeutics Consumption Market Share by Regions 2015-2020 Table 26. Global mRNA Vaccines & Therapeutics Value by Regions 2015-2020 ($ Millions) Table 27. Global mRNA Vaccines & Therapeutics Value Market Share by Regions 2015-2020 Table 28. Americas mRNA Vaccines & Therapeutics Consumption by Countries (2015-2020) (M Doses) Table 29. Americas mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2015-2020) Table 30. Americas mRNA Vaccines & Therapeutics Value by Countries (2015-2020) ($ Millions) Table 31. Americas mRNA Vaccines & Therapeutics Value Market Share by Countries (2015-2020) Table 32. Americas mRNA Vaccines & Therapeutics Consumption by Type (2015-2020) (M Doses) Table 33. Americas mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020) Table 34. Americas mRNA Vaccines & Therapeutics Consumption by Application (2015-2020) (M Doses) Table 35. Americas mRNA Vaccines & Therapeutics Consumption Market Share by Application (2015-2020) Table 36. APAC mRNA Vaccines & Therapeutics Consumption by Regions (2015-2020) (M Doses) Table 37. APAC mRNA Vaccines & Therapeutics Consumption Market Share by Regions (2015-2020) Table 38. APAC mRNA Vaccines & Therapeutics Value by Regions (2015-2020) ($ Millions) Table 39. APAC mRNA Vaccines & Therapeutics Value Market Share by Regions (2015-2020) Table 40. APAC mRNA Vaccines & Therapeutics Consumption by Type (2015-2020) (M Doses) Table 41. APAC mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020) Table 42. APAC mRNA Vaccines & Therapeutics Consumption by Application (2015-2020) (M Doses) Table 43. APAC mRNA Vaccines & Therapeutics Consumption Market Share by Application (2015-2020) Table 44. Europe mRNA Vaccines & Therapeutics Consumption by Countries (2015-2020) (M Doses) Table 45. Europe mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2015-2020) Table 46. Europe mRNA Vaccines & Therapeutics Value by Countries (2015-2020) ($ Millions) Table 47. Europe mRNA Vaccines & Therapeutics Value Market Share by Countries (2015-2020) Table 48. Europe mRNA Vaccines & Therapeutics Consumption by Type (2015-2020) (M Doses) Table 49. Europe mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020) Table 50. Europe mRNA Vaccines & Therapeutics Consumption by Application (2015-2020) (M Doses) Table 51. Europe mRNA Vaccines & Therapeutics Consumption Market Share by Application (2015-2020) Table 52. Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Countries (2015-2020) (M Doses) Table 53. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Countries (2015-2020) Table 54. Middle East & Africa mRNA Vaccines & Therapeutics Value by Countries (2015-2020) ($ Millions) Table 55. Middle East & Africa mRNA Vaccines & Therapeutics Value Market Share by Countries (2015-2020) Table 56. Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Type (2015-2020) (M Doses) Table 57. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020) Table 58. Middle East & Africa mRNA Vaccines & Therapeutics Consumption by Application (2015-2020) (M Doses) Table 59. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Application (2015-2020) Table 60. mRNA Vaccines & Therapeutics Distributors List Table 61. mRNA Vaccines & Therapeutics Customer List Table 62. Global mRNA Vaccines & Therapeutics Consumption Forecast by Countries (2021-2025) (M Doses) Table 63. Global mRNA Vaccines & Therapeutics Consumption Market Forecast by Regions Table 64. Global mRNA Vaccines & Therapeutics Value Forecast by Countries (2021-2025) ($ Millions) Table 65. Global mRNA Vaccines & Therapeutics Value Market Share Forecast by Regions Table 66. Global mRNA Vaccines & Therapeutics Consumption Forecast by Type (2021-2025) (M Doses) Table 67. Global mRNA Vaccines & Therapeutics Consumption Market Share Forecast by Type (2021-2025) Table 68. Global mRNA Vaccines & Therapeutics Value Forecast by Type (2021-2025) ($ Millions) Table 69. Global mRNA Vaccines & Therapeutics Value Market Share Forecast by Type (2021-2025) Table 70. Global mRNA Vaccines & Therapeutics Consumption Forecast by Application (2021-2025) (M Doses) Table 71. Global mRNA Vaccines & Therapeutics Consumption Market Share Forecast by Application (2021-2025) Table 72. Global mRNA Vaccines & Therapeutics Value Forecast by Application (2021-2025) ($ Millions) Table 73. Global mRNA Vaccines & Therapeutics Value Market Share Forecast by Application (2021-2025) Table 74. Moderna Therapeutics Product Offered Table 75. Moderna Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 76. Moderna Therapeutics Main Business Table 77. Moderna Therapeutics Latest Developments Table 78. Moderna Therapeutics Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 79. Tiba Biotechnology Product Offered Table 80. Tiba Biotechnology mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 81. Tiba Biotechnology Main Business Table 82. Tiba Biotechnology Latest Developments Table 83. Tiba Biotechnology Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 84. CureVac Product Offered Table 85. CureVac mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 86. CureVac Main Business Table 87. CureVac Latest Developments Table 88. CureVac Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 89. BioNTech Product Offered Table 90. BioNTech mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 91. BioNTech Main Business Table 92. BioNTech Latest Developments Table 93. BioNTech Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 94. Sangamo Therapeutics Product Offered Table 95. Sangamo Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 96. Sangamo Therapeutics Main Business Table 97. Sangamo Therapeutics Latest Developments Table 98. Sangamo Therapeutics Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 99. Translate Bio Product Offered Table 100. Translate Bio mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 101. Translate Bio Main Business Table 102. Translate Bio Latest Developments Table 103. Translate Bio Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 104. eTheRNA Product Offered Table 105. eTheRNA Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 106. eTheRNA Main Business Table 107. eTheRNA Latest Developments Table 108. eTheRNA mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 109. Argos Therapeutics Product Offered Table 110. Argos Therapeutics mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 111. Argos Therapeutics Main Business Table 112. Argos Therapeutics Latest Developments Table 113. Argos Therapeutics Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 114. Ethris Product Offered Table 115. Ethris mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 116. Ethris Main Business Table 117. Ethris Latest Developments Table 118. Ethris Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors Table 119. In-Cell-Art Product Offered Table 120. In-Cell-Art mRNA Vaccines & Therapeutics Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2018-2020E) Table 121. In-Cell-Art Main Business Table 122. In-Cell-Art Latest Developments Table 123. In-Cell-Art Basic Information, Company Total Revenue (in $ million), mRNA Vaccines & Therapeutics Manufacturing Base, Sales Area and Its Competitors List of Figures Figure 1. Picture of mRNA Vaccines & Therapeutics Figure 2. mRNA Vaccines & Therapeutics Report Years Considered Figure 3. Market Research Methodology Figure 4. Global mRNA Vaccines & Therapeutics Consumption Growth Rate 2015-2025 (M Doses) Figure 5. Global mRNA Vaccines & Therapeutics Value Growth Rate 2015-2025 ($ Millions) Figure 6. Product Picture of Infectious Disease Vaccines Figure 7. Product Picture of Cancer Vaccines Figure 8. Global mRNA Vaccines & Therapeutics Consumption Market Share by Type (2015-2020) Figure 9. Global mRNA Vaccines & Therapeutics Value Market Share by Type (2015-2020) Figure 10. mRNA Vaccines & Therapeutics Consumed in Infectious Disease Figure 11. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2015-2020) (M Doses) Figure 12. Global mRNA Vaccines & Therapeutics Market: Infectious Disease (2015-2020) ($ Millions) Figure 13. mRNA Vaccines & Therapeutics Consumed in Cancer Figure 14. Global mRNA Vaccines & Therapeutics Market: Cancer (2015-2020) (M Doses) Figure 15. Global mRNA Vaccines & Therapeutics Market: Cancer (2015-2020) ($ Millions) Figure 16. Global mRNA Vaccines & Therapeutics Consumption Market Share by Application (2015-2020) Figure 17. Global mRNA Vaccines & Therapeutics Value Market Share by Application (2015-2020) Figure 18. Global mRNA Vaccines & Therapeutics Sales Market Share by Company in 2017 Figure 19. Global mRNA Vaccines & Therapeutics Sales Market Share by Company in 2019 Figure 20. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2017 Figure 21. Global mRNA Vaccines & Therapeutics Revenue Market Share by Company in 2019 Figure 22. Global mRNA Vaccines & Therapeutics Sale Price by Company in 2019 Figure 23. Global mRNA Vaccines & Therapeutics Consumption Market Share by Regions 2015-2020 Figure 24. Global mRNA Vaccines & Therapeutics Value Market Share by Regions 2015-2020 Figure 25. Americas mRNA Vaccines & Therapeutics Consumption 2015-2020 (M Doses) Figure 26. Americas mRNA Vaccines & Therapeutics Value 2015-2020 ($ Millions) Figure 27. APAC mRNA Vaccines & Therapeutics Consumption 2015-2020 (M Doses) Figure 28. APAC mRNA Vaccines & Therapeutics Value 2015-2020 ($ Millions) Figure 29. Europe mRNA Vaccines & Therapeutics Consumption 2015-2020 (M Doses) Figure 30. Europe mRNA Vaccines & Therapeutics Value 2015-2020 ($ Millions) Figure 31. Middle East & Africa mRNA Vaccines & Therapeutics Consumption 2015-2020 (M Doses) Figure 32. Middle East & Africa mRNA Vaccines & Therapeutics Value 2015-2020 ($ Millions) Figure 33. Americas mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2019 Figure 34. Americas mRNA Vaccines & Therapeutics Value Market Share by Countries in 2019 Figure 35. Americas mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2019 Figure 36. Americas mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2019 Figure 37. United States mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 38. United States mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 39. Canada mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 40. Canada mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 41. Mexico mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 42. Mexico mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 43. APAC mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2019 Figure 44. APAC mRNA Vaccines & Therapeutics Value Market Share by Regions in 2019 Figure 45. APAC mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2019 Figure 46. APAC mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2019 Figure 47. China mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 48. China mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 49. Japan mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 50. Japan mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 51. Korea mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 52. Korea mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 53. Southeast Asia mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 54. Southeast Asia mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 55. India mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 56. India mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 57. Australia mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 58. Australia mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 59. Europe mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2019 Figure 60. Europe mRNA Vaccines & Therapeutics Value Market Share by Countries in 2019 Figure 61. Europe mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2019 Figure 62. Europe mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2019 Figure 63. Germany mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 64. Germany mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 65. France mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 66. France mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 67. UK mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 68. UK mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 69. Italy mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 70. Italy mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 71. Russia mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 72. Russia mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 73. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Countries in 2019 Figure 74. Middle East & Africa mRNA Vaccines & Therapeutics Value Market Share by Countries in 2019 Figure 75. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Type in 2019 Figure 76. Middle East & Africa mRNA Vaccines & Therapeutics Consumption Market Share by Application in 2019 Figure 77. Egypt mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 78. Egypt mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 79. South Africa mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 80. South Africa mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 81. Israel mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 82. Israel mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 83. Turkey mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 84. Turkey mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 85. GCC Countries mRNA Vaccines & Therapeutics Consumption Growth 2015-2020 (M Doses) Figure 86. GCC Countries mRNA Vaccines & Therapeutics Value Growth 2015-2020 ($ Millions) Figure 87. Global mRNA Vaccines & Therapeutics Consumption Growth Rate Forecast (2021-2025) (M Doses) Figure 88. Global mRNA Vaccines & Therapeutics Value Growth Rate Forecast (2021-2025) ($ Millions) Figure 89. Americas mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 90. Americas mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 91. APAC mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 92. APAC mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 93. Europe mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 94. Europe mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 95. Middle East & Africa mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 96. Middle East & Africa mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 97. United States mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 98. United States mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 99. Canada mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 100. Canada mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 101. Mexico mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 102. Mexico mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 103. Brazil mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 104. Brazil mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 105. China mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 106. China mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 107. Japan mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 108. Japan mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 109. Korea mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 110. Korea mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 111. Southeast Asia mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 112. Southeast Asia mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 113. India mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 114. India mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 115. Australia mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 116. Australia mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 117. Germany mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 118. Germany mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 119. France mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 120. France mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 121. UK mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 122. UK mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 123. Italy mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 124. Italy mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 125. Russia mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 126. Russia mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 127. Spain mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 128. Spain mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 129. Egypt mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 130. Egypt mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 131. South Africa mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 132. South Africa mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 133. Israel mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 134. Israel mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 135. Turkey mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 136. Turkey mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 137. GCC Countries mRNA Vaccines & Therapeutics Consumption 2021-2025 (M Doses) Figure 138. GCC Countries mRNA Vaccines & Therapeutics Value 2021-2025 ($ Millions) Figure 139. Moderna Therapeutics mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 140. Tiba Biotechnology mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 141. CureVac mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 142. BioNTech mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 143. Sangamo Therapeutics mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 144. Translate Bio mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 145. eTheRNA mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 146. Argos Therapeutics mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 147. Ethris mRNA Vaccines & Therapeutics Market Share (2018-2020) Figure 148. In-Cell-Art mRNA Vaccines & Therapeutics Market Share (2018-2020)

Name*
Email ID*
Company*
Phone (With Country Code)*
What is/are your question(s)?:
Publisher: LP Information Inc
Chat with us